WOMEN' PREFERENCES FOR CHEMOTHERAPY IN THE TREATMENT OF EARLY STAGE BREAST CANCER

被引:0
|
作者
Tang, C. H. [1 ]
Hung, Y. W. [1 ]
Sung, C. Y. [1 ]
Chuang, P. Y. [1 ]
Chen, T. F. [1 ]
机构
[1] Taipei Med Univ, Taipei, Taiwan
关键词
D O I
10.1016/j.jval.2012.03.1217
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A225 / A225
页数:1
相关论文
共 50 条
  • [31] Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
    Arran K. Turnbull
    Samir Patel
    Carlos Martinez-Perez
    Anne Rigg
    Olga Oikonomidou
    [J]. Breast Cancer Research and Treatment, 2021, 186 : 237 - 245
  • [32] Risk of chemotherapy-related amenorrhoea (CRA) in premenopausal women undergoing chemotherapy for early stage breast cancer
    Turnbull, Arran K.
    Patel, Samir
    Martinez-Perez, Carlos
    Rigg, Anne
    Oikonomidou, Olga
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 237 - 245
  • [33] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    [J]. WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [34] Use of the prone position in radiation treatment for women with early stage breast cancer
    Algan, O
    Fowble, B
    McNeeley, S
    Fein, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (05): : 1137 - 1140
  • [35] Lumpectomy with tamoxifen as primary treatment for elderly women with early stage breast cancer
    Benhaim, DI
    Lopchinsky, R
    Tartter, PI
    [J]. AMERICAN JOURNAL OF SURGERY, 2000, 180 (03): : 162 - 166
  • [36] Spotlight on triptorelin in the treatment of premenopausal women with early-stage breast cancer
    Venturelli, Marta
    Guaitoli, Giorgia
    Omarini, Claudia
    Moscetti, Luca
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2018, 10 : 39 - 49
  • [37] Concomitant versus sequential chemotherapy in the treatment of early-stage and metastatic breast cancer
    Ocana, Alberto
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    [J]. CLINICAL BREAST CANCER, 2006, 6 (06) : 495 - 504
  • [38] PATIENT PREFERENCES FOR TREATMENT ATTRIBUTES AND ENDPOINTS IN NEOADJUVANT THERAPY FOR EARLY-STAGE BREAST CANCER
    Batchelder, L.
    Gueroult-Accolas, L.
    Anastasaki, E.
    Dunton, K.
    Lueftner, D.
    Oswald, C.
    Ryan, J.
    Schmitt, D.
    Steinerova, V
    Varghese, D.
    Johal, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S452 - S453
  • [39] Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer
    Knuttel, Floortje M.
    van den Bosch, Maurice A. A. J.
    Young-Afat, Danny A.
    Emaus, Marleen J.
    van den Bongard, Desiree H. J. G.
    Witkamp, Arjen J.
    Verkooijen, Helena M.
    [J]. VALUE IN HEALTH, 2017, 20 (03) : 474 - 480
  • [40] Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer
    Ruddy, K. J.
    Partridge, A. H.
    Gelber, S.
    Schapira, L.
    Abusief, M.
    Meyer, M.
    Winer, E. P.
    Ginsburg, E. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)